JPS61129129A - 抗腫瘍剤 - Google Patents
抗腫瘍剤Info
- Publication number
- JPS61129129A JPS61129129A JP25128484A JP25128484A JPS61129129A JP S61129129 A JPS61129129 A JP S61129129A JP 25128484 A JP25128484 A JP 25128484A JP 25128484 A JP25128484 A JP 25128484A JP S61129129 A JPS61129129 A JP S61129129A
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- antitumor agent
- tumor
- formula
- agent containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25128484A JPS61129129A (ja) | 1984-11-28 | 1984-11-28 | 抗腫瘍剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25128484A JPS61129129A (ja) | 1984-11-28 | 1984-11-28 | 抗腫瘍剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61129129A true JPS61129129A (ja) | 1986-06-17 |
JPH0430924B2 JPH0430924B2 (ru) | 1992-05-25 |
Family
ID=17220510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP25128484A Granted JPS61129129A (ja) | 1984-11-28 | 1984-11-28 | 抗腫瘍剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61129129A (ru) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0784055A4 (en) * | 1994-09-26 | 1998-01-07 | Daiichi Seiyaku Co | PYRIMIDINYLPYRAZOLE DERIVATIVE |
EP1022270A1 (en) * | 1997-01-27 | 2000-07-26 | Daiichi Pharmaceutical Co., Ltd. | Pyrazole derivatives |
US6552018B1 (en) | 1997-01-27 | 2003-04-22 | Daiichi Pharmaceutical Co., Ltd. | Pyrazole derivatives |
FR2850379A1 (fr) * | 2003-01-28 | 2004-07-30 | Aventis Pharma Sa | Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation |
WO2004078732A1 (fr) * | 2003-01-28 | 2004-09-16 | Aventis Pharma S.A. | Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation |
JP2012522847A (ja) * | 2009-04-06 | 2012-09-27 | アジオス ファーマシューティカルズ, インコーポレイテッド | ピルビン酸キナーゼm2調節剤、治療組成物および関連する使用方法 |
US8889667B2 (en) | 2010-12-29 | 2014-11-18 | Agios Pharmaceuticals, Inc | Therapeutic compounds and compositions |
US9115086B2 (en) | 2009-06-29 | 2015-08-25 | Agios Pharmaceuticals, Inc. | Therapeutic compositions and related methods of use |
US9181231B2 (en) | 2011-05-03 | 2015-11-10 | Agios Pharmaceuticals, Inc | Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia |
US9221792B2 (en) | 2010-12-17 | 2015-12-29 | Agios Pharmaceuticals, Inc | N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators |
US9328077B2 (en) | 2010-12-21 | 2016-05-03 | Agios Pharmaceuticals, Inc | Bicyclic PKM2 activators |
US9365545B2 (en) | 2013-03-15 | 2016-06-14 | Agios Pharmaceuticals, Inc | Therapeutic compounds and compositions |
US9980961B2 (en) | 2011-05-03 | 2018-05-29 | Agios Pharmaceuticals, Inc. | Pyruvate kinase activators for use in therapy |
US10029987B2 (en) | 2009-06-29 | 2018-07-24 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
US11234976B2 (en) | 2015-06-11 | 2022-02-01 | Agios Pharmaceuticals, Inc. | Methods of using pyruvate kinase activators |
-
1984
- 1984-11-28 JP JP25128484A patent/JPS61129129A/ja active Granted
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5852019A (en) * | 1994-09-26 | 1998-12-22 | Daiichi Pharmaceutical Co., Ltd. | Pyrimidinylpyrazole derivatives |
EP0784055A4 (en) * | 1994-09-26 | 1998-01-07 | Daiichi Seiyaku Co | PYRIMIDINYLPYRAZOLE DERIVATIVE |
EP1022270A1 (en) * | 1997-01-27 | 2000-07-26 | Daiichi Pharmaceutical Co., Ltd. | Pyrazole derivatives |
EP1022270A4 (en) * | 1997-01-27 | 2002-01-30 | Daiichi Seiyaku Co | PIRAZOLE DERIVATIVES |
US6552018B1 (en) | 1997-01-27 | 2003-04-22 | Daiichi Pharmaceutical Co., Ltd. | Pyrazole derivatives |
FR2850379A1 (fr) * | 2003-01-28 | 2004-07-30 | Aventis Pharma Sa | Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation |
WO2004078732A1 (fr) * | 2003-01-28 | 2004-09-16 | Aventis Pharma S.A. | Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation |
US9657004B2 (en) | 2009-04-06 | 2017-05-23 | Agios Pharmaceuticals, Inc | Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use |
JP2012522847A (ja) * | 2009-04-06 | 2012-09-27 | アジオス ファーマシューティカルズ, インコーポレイテッド | ピルビン酸キナーゼm2調節剤、治療組成物および関連する使用方法 |
US9938259B2 (en) | 2009-04-06 | 2018-04-10 | Agios Pharmaceuticals, Inc. | Therapeutic compositions and related methods of use |
US10029987B2 (en) | 2009-06-29 | 2018-07-24 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
US11866411B2 (en) | 2009-06-29 | 2024-01-09 | Agios Pharmaceutical, Inc. | Therapeutic compounds and compositions |
USRE49582E1 (en) | 2009-06-29 | 2023-07-18 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
US9115086B2 (en) | 2009-06-29 | 2015-08-25 | Agios Pharmaceuticals, Inc. | Therapeutic compositions and related methods of use |
US10988448B2 (en) | 2009-06-29 | 2021-04-27 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
US9221792B2 (en) | 2010-12-17 | 2015-12-29 | Agios Pharmaceuticals, Inc | N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators |
US9328077B2 (en) | 2010-12-21 | 2016-05-03 | Agios Pharmaceuticals, Inc | Bicyclic PKM2 activators |
US10087169B2 (en) | 2010-12-21 | 2018-10-02 | Agios Pharmaceuticals, Inc. | Bicyclic PKM2 activators |
US9199968B2 (en) | 2010-12-29 | 2015-12-01 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
US8889667B2 (en) | 2010-12-29 | 2014-11-18 | Agios Pharmaceuticals, Inc | Therapeutic compounds and compositions |
US10632114B2 (en) | 2011-05-03 | 2020-04-28 | Agios Pharmaceuticals, Inc. | Pyruvate kinase activators for use in therapy |
US9980961B2 (en) | 2011-05-03 | 2018-05-29 | Agios Pharmaceuticals, Inc. | Pyruvate kinase activators for use in therapy |
US9181231B2 (en) | 2011-05-03 | 2015-11-10 | Agios Pharmaceuticals, Inc | Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia |
US11793806B2 (en) | 2011-05-03 | 2023-10-24 | Agios Pharmaceuticals, Inc. | Pyruvate kinase activators for use in therapy |
US9365545B2 (en) | 2013-03-15 | 2016-06-14 | Agios Pharmaceuticals, Inc | Therapeutic compounds and compositions |
US11234976B2 (en) | 2015-06-11 | 2022-02-01 | Agios Pharmaceuticals, Inc. | Methods of using pyruvate kinase activators |
Also Published As
Publication number | Publication date |
---|---|
JPH0430924B2 (ru) | 1992-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS61129129A (ja) | 抗腫瘍剤 | |
KR19980064024A (ko) | 약학 조성물 | |
EP0774255A1 (en) | Use of ursolic acid for the manufacture of a medicament for suppressing metastasis | |
JP5118863B2 (ja) | 催眠用医薬組成物 | |
JPH06500537A (ja) | アテローム硬化症の治療のためのアリールヒドロキシ尿素化合物の使用 | |
US4892876A (en) | Method for inhibiting HIV and an pharmaceutical composition therefor | |
JPS63267781A (ja) | 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤 | |
JPS61129124A (ja) | 抗腫瘍剤 | |
US3519712A (en) | Therapeutic compositions comprising n-methylglucamine and coumermycin or salts thereof | |
US3906107A (en) | Aminoalkyl sulfate esters with diuretic activity | |
EP1203585B1 (en) | Anti-ischemic agent | |
JPS61129126A (ja) | 抗腫瘍剤 | |
JPS5938207B2 (ja) | 腎疾患治療剤 | |
JPS61134315A (ja) | 解熱鎮痛剤 | |
JPS6058726B2 (ja) | プリン誘導体を有効成分として含有する抗アレルギ−,鎮痛,鎮静剤 | |
JPS61129127A (ja) | 抗腫瘍剤 | |
WO1995020388A1 (fr) | Medicaments anti-vih | |
JPH0616561A (ja) | 抗レトロウイルス剤 | |
JPS61129128A (ja) | 抗腫瘍剤 | |
JPH02178227A (ja) | 腎炎治療剤 | |
JPS61129121A (ja) | 抗腫瘍剤 | |
Barbour et al. | The use of carbethoxysyringoyl methylreserpate in hypertension | |
JPS61130222A (ja) | 抗腫瘍剤 | |
JPS61130218A (ja) | 抗腫瘍剤 | |
JPS61130221A (ja) | 抗腫瘍剤 |